Trade OPKO Health, Inc. - OPK CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.0180 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.456 |
| Open | 1.416 |
| 1-Year Change | 16.5% |
| Day's Range | 1.396 - 1.426 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 24, 2025 | 1.4560 | -0.0100 | -0.68% | 1.4660 | 1.4660 | 1.4260 |
| Apr 23, 2025 | 1.4460 | -0.0500 | -3.34% | 1.4960 | 1.5360 | 1.4360 |
| Apr 22, 2025 | 1.4060 | 0.0100 | 0.72% | 1.3960 | 1.4360 | 1.3760 |
| Apr 21, 2025 | 1.3660 | -0.0300 | -2.15% | 1.3960 | 1.4060 | 1.3660 |
| Apr 17, 2025 | 1.4160 | 0.0100 | 0.71% | 1.4060 | 1.4260 | 1.3960 |
| Apr 16, 2025 | 1.4160 | -0.0100 | -0.70% | 1.4260 | 1.4360 | 1.3960 |
| Apr 15, 2025 | 1.4360 | 0.0100 | 0.70% | 1.4260 | 1.4460 | 1.3960 |
| Apr 14, 2025 | 1.4160 | 0.0100 | 0.71% | 1.4060 | 1.4260 | 1.3960 |
| Apr 11, 2025 | 1.4060 | 0.0800 | 6.03% | 1.3260 | 1.4060 | 1.3260 |
| Apr 10, 2025 | 1.3460 | -0.0900 | -6.27% | 1.4360 | 1.4460 | 1.3360 |
| Apr 9, 2025 | 1.4760 | 0.0500 | 3.51% | 1.4260 | 1.5060 | 1.3860 |
| Apr 8, 2025 | 1.4560 | -0.0900 | -5.82% | 1.5460 | 1.5460 | 1.4360 |
| Apr 7, 2025 | 1.5160 | 0.0300 | 2.02% | 1.4860 | 1.5660 | 1.4560 |
| Apr 4, 2025 | 1.5360 | -0.0300 | -1.92% | 1.5660 | 1.5860 | 1.5360 |
| Apr 3, 2025 | 1.5660 | -0.0400 | -2.49% | 1.6060 | 1.6260 | 1.5560 |
| Apr 2, 2025 | 1.6460 | 0.0100 | 0.61% | 1.6360 | 1.6660 | 1.5960 |
| Apr 1, 2025 | 1.6560 | -0.0100 | -0.60% | 1.6660 | 1.6760 | 1.6360 |
| Mar 31, 2025 | 1.6560 | -0.0100 | -0.60% | 1.6660 | 1.6760 | 1.6360 |
| Mar 28, 2025 | 1.6960 | -0.0100 | -0.59% | 1.7060 | 1.7360 | 1.6760 |
| Mar 27, 2025 | 1.7260 | -0.0400 | -2.27% | 1.7660 | 1.7860 | 1.7260 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
OPKO Health, Inc. Company profile
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company''s Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women''s health, and correctional healthcare to physician offices, clinics, hospitals, employers and governmental units, as well as 4Kscore prostate cancer testing services. The company''s Pharmaceutical segment offers Rayaldee for treatment for secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and associated obesity that is in Phase IIb trials; and hGH-CTP, a once-weekly human growth hormone injection that completed Phase III clinical trial in partnership with Pfizer, Inc. This segment develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins. It also specialty active pharmaceutical ingredients; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and imports, markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. In addition, the company operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. OPKO Health, Inc. was incorporated in 1991 and is headquartered in Miami, Florida.| Industry: | Medical & Diagnostic Laboratories |
4400 Biscayne Blvd.
MIAMI
FLORIDA 33137
US
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com